Orchestra BioMed Holdings, Inc.

General ticker "OBIO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $137.9M (TTM average)

Orchestra BioMed Holdings, Inc. follows the US Stock Market performance with the rate: 41.5%.

Estimated limits based on current volatility of 4.9%: low 4.18$, high 4.61$

Factors to consider:

  • Total employees count: 56 as of 2023
  • Price in estimated range
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.65$, 7.46$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.28$, 6.57$]

Financial Metrics affecting the OBIO estimates:

  • Positive: with PPE of -2.9 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -29.70 <= 0.01
  • Positive: 42.68 < Shareholder equity ratio, % of 43.27 <= 64.29
  • Positive: Investing cash flow per share per price, % of 7.69 > -0.63
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Net income

Similar symbols

Short-term OBIO quotes

Long-term OBIO plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $3.53MM $2.76MM $2.64MM
Operating Expenses $36.19MM $54.27MM $66.94MM
Operating Income $-32.66MM $-51.51MM $-64.30MM
Non-Operating Income $-0.95MM $2.39MM $3.28MM
R&D Expense $21.95MM $33.82MM $42.80MM
Income(Loss) $-33.61MM $-49.12MM $-61.02MM
Profit(Loss)* $-33.61MM $-49.12MM $-61.02MM
Stockholders Equity $52.53MM $68.04MM $32.96MM
Inventory $0.28MM $0.15MM $0.17MM
Assets $95.57MM $95.21MM $76.17MM
Operating Cash Flow $-29.29MM $-46.13MM $-50.56MM
Capital expenditure $0.59MM $0.08MM $0.29MM
Investing Cash Flow $-64.12MM $10.69MM $13.09MM
Financing Cash Flow $103.26MM $46.22MM $29.17MM
Earnings Per Share** $-1.32 $-1.48 $-1.66

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.